Why study metabolic pathways together? Learn how hormone signals, nutrient sensing and energy production intersect—and why that matters for targeted therapies. Learn more: https://bit.ly/3WTawMd #Biotech #MetabolicPathways #ObesityResearch
About us
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems. Interactions with our customers, partners and vendors are central to everything we do, and we value those relationships. We seek out and build connections across the globe and in our local communities because creative problem solving requires a network of diverse ideas and viewpoints. We develop and evolve technologies and instrumentation in collaboration with scientists and researchers around the globe. From simple cloning vectors used to address fundamental questions in biology to bioluminescent assays that help us monitor food safety and water quality, we work side-by-side with our partners in academic, industrial and government institutions to bring the best minds to bear on the toughest questions. Since 1978, we have done this all with a steadfast commitment to sustainable business models that protect our environment, inspire and develop our employees as individuals, support the wellbeing and growth of our communities, and strengthen our relationships with our customers. With 16 branches around the world, Promega products are used by a global community of life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification.
- Website
-
http://www.promega.com
External link for Promega Corporation
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Madison, WI
- Type
- Privately Held
- Founded
- 1978
- Specialties
- Nucleic Acid Isolation, Protein Expression and Analysis, Cell-Based and Biochemical Assays, Luminescent Chemistries, Custom Manufacturing, Custom Assay Services, Energy Metabolism, Reporter Bioasssays, Nucleic Acid Amplification, and Protein Degradation
Locations
Employees at Promega Corporation
Updates
-
Heading to #AMP2025? Let’s connect! Whether you’re scaling capacity or looking for a true strategic partner, we’re here to collaborate. From clinical assay development and lyophilization support to innovative Maxwell® chemistries, we bring solutions that clear the path for your clinical workflow. #MolecularDiagnostics #ClinicalDiagnostics #PrecisionMedicine
-
Immunoassays don’t have to be a tradeoff between performance and simplicity. Discover how the Lumit® Flex platform brings no-wash, high-sensitivity detection to complex samples—serum, plasma, supernatants and more—with a straightforward “Add–Mix–Read” workflow. Whether you’re developing for point-of-care or scaling up for automation, this system adapts. Join us to explore modern immunoassay development—built for today’s needs. https://bit.ly/4nZ3dhZ
-
Why do mosquitoes seem to love some people more than others? A new study suggests your habits—like drinking beer or skipping sunscreen—might make you a more tempting target. Read how festivalgoers helped scientists uncover what turns some of us into mosquito magnets: https://bit.ly/48BS4Ps
-
-
Want to tag proteins without disrupting biology? Let’s talk knock-ins. Join us for a second live session of our webinar on CRISPR knock-in cell lines—designed to help you build endogenous models with confidence. Learn how inserting tags like HiBiT, NanoLuc®, or HaloTag® can support sensitive, artifact-free detection in live cells. Get a quick overview, then bring your questions for a live Q&A with our experts. Whether you're planning your first knock-in or optimizing your next one, this is your chance to ask the details that matter. https://bit.ly/4onSb5L
-
-
When veterinarians test pigs for influenza A, they’re helping protect both animal and human health. Promega and Longhorn Vaccines and Diagnostics have partnered to make influenza detection in animals faster, safer, and easier—without the need for BSL-3 containment. This field-ready workflow supports real-time, One Health–driven disease surveillance. Read more about this collaboration on our blog: https://bit.ly/4otAkdW
-
Promega Corporation reposted this
The Promega Collection just got bigger! We've added 250+ plasmids, including: • Human ORFs fused with NanoLuc®, HaloTag®, SmBiT, & LgBiT • NanoBiT® & NanoBRET® plasmid pairs for live-cell assays • 40+ luciferase reporters to study DNA damage response, hypoxia & more Available to industry and academic researchers with no MTA required. See what's new: https://hubs.la/Q03LVtBN0
-
-
CAR-T therapies rely on modified T cells, and keeping those cells traceable through manufacturing is essential for safety and compliance. Short tandem repeat (STR) analysis helps confirm donor identity, detect cross-contamination, and support regulatory expectations. With the GenePrint® 24 System and Spectrum Compact CE System, you can generate informative STR profiles in-house bringing confidence and control to CAR-T identity testing. Read the blog: https://bit.ly/48AcCI6 See how sequencing and STR analysis strengthen CAR-T manufacturing: https://bit.ly/4nTwASP
-
-
Stutter artifacts have long complicated STR analysis, obscuring true alleles, inflating interpretation time and creating courtroom challenges. Earlier this year, Promega presented new data on the Paradyme™ 27GY STR System, built with Reduced-Stutter Polymerase technology. The results showed a dramatic reduction in stutter, producing cleaner electropherograms that simplify mixture deconvolution and make contributor estimates more reliable. By minimizing artifacts at the source, Paradyme will help laboratories achieve clearer profiles and greater consistency in their analyses. Clarity you can see. Results you can trust. Read the full poster here: https://bit.ly/4onrQVq Learn more about Paradyme: https://bit.ly/47apEcP
-
-
Cell therapies, both patient-derived (autologous) and donor-based (allogeneic), are revolutionizing medicine. Want to learn how Promega R&D is thinking about cell therapy QC workflows? Visit our blog. https://lnkd.in/eTWvGKER #celltherapy #biologics
This content isn’t available here
Access this content and more in the LinkedIn app